Definium Therapeutics (DFTX) Shares Outstanding (2020 - 2026)

Definium Therapeutics (DFTX) has 6 years of Shares Outstanding (Entity) data on file, last reported at $104.0 million in Q1 2026.

• On a quarterly basis, Shares Outstanding (Entity) rose 37.79% year-over-year to $104.0 million in Q1 2026; TTM through Mar 2026 was $104.0 million, a 37.79% increase from a year earlier, with the FY2025 full-year figure at $98.8 million, up 31.52% from the prior year.
• Shares Outstanding (Entity) for Q1 2026 stood at $104.0 million, up from $98.8 million in the prior quarter.
• Over the last five years, Shares Outstanding (Entity) for DFTX reached as high as $104.0 million in Q1 2026 and fell as low as $28.2 million in Q1 2022.
• Historically, Shares Outstanding (Entity) has averaged $73.6 million across 4 years, with a median of $75.7 million in 2025.
• On a YoY basis, Shares Outstanding (Entity) climbed as much as 57.77% in 2025 and fell as far as 5.9% in 2025.
• Year by year, Shares Outstanding (Entity) stood at $28.2 million in 2022, then soared by 166.65% to $75.1 million in 2024, then soared by 31.52% to $98.8 million in 2025, then advanced by 5.33% to $104.0 million in 2026.
• Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $104.0 million in Q1 2026, $98.8 million in Q4 2025, and $76.8 million in Q3 2025.